Icon Clinical Research Limited

Icon Clinical Research Limited is a company in Dublin, Ireland that has taken part in 6 EU-funded projects since 2015, receiving €2.6M in EU funding.

EU funding received€2.6M
EU projects6
As coordinator0
Running now0
First EU project2015
Latest project2019
CountryIreland
EU registration (PIC)931760370
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Icon Clinical Research Limited's own share of each project, not the project's full budget.

  • Horizon 2020€2.6M · 6 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • MOBILISE-DPartner

    Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • CareHDPartner

    Patient Centered Connected Health Model of Care for Huntingtons Disease

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €27ktheir share
  • HIPGENPartner

    Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €1.3Mtheir share
  • PACEPartner

    A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €625ktheir share
  • 3D NEONETPartner

    Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  • MIROCALSPartner

    Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €659ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • amyotrophic lateral sclerosis
  • breast cancer
  • cells technologies
  • diabetes
  • drug discovery
  • gene therapy
  • graft versus host disease
  • immunology
  • mortality
  • pharmaceutical drugs
  • prostate cancer
  • public health
  • retinopathy
  • sensors

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime